TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
TD Cowen維持對Elevance Health的買入評級,將目標價下調至589美元
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $624 to $589.
TD Cowen 分析師Ryan Langston 保持對Elevance Health(NYSE:ELV)的買入評級,將目標股價下調至$589。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。